Cited 14 time in
Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Maharjan, Ravi | - |
| dc.contributor.author | Kim, Ki Hyun | - |
| dc.contributor.author | Lee, Kyeong | - |
| dc.contributor.author | Han, Hyo-Kyung | - |
| dc.contributor.author | Jeong, Seong Hoon | - |
| dc.date.accessioned | 2025-03-05T01:42:51Z | - |
| dc.date.available | 2025-03-05T01:42:51Z | - |
| dc.date.issued | 2024-11 | - |
| dc.identifier.issn | 2095-1779 | - |
| dc.identifier.issn | 2214-0883 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/57780 | - |
| dc.description.abstract | To enhance the efficiency of vaccine manufacturing, this study focuses on optimizing the microfluidic conditions and lipid mix ratios of messenger RNA-lipid nanoparticles (mRNA-LNP). Different mRNA-LNP formulations (n = 24) were developed using an I-optimal design, where machine learning tools (XGBoost/Bayesian optimization and self-validated ensemble (SVEM)) were used to optimize the process and predict lipid mix ratio. The investigation included material attributes, their respective ratios, and process attributes. The critical responses like particle size (PS), polydispersity index (PDI), Zeta potential, pKa, heat trend cycle, encapsulation efficiency (EE), recovery ratio, and encapsulated mRNA were evaluated. Overall prediction of SVEM (>97%) was comparably better than that of XGBoost/Bayesian optimization (>94%). Moreover, in actual experimental outcomes, SVEM prediction is close to the actual data as confirmed by the experimental PS (94-96 nm) is close to the predicted one (95-97 nm). The other parameters including PDI and EE were also close to the actual experimental data. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of Xi'an Jiaotong University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | - |
| dc.format.extent | 16 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | ELSEVIER | - |
| dc.title | Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches | - |
| dc.type | Article | - |
| dc.publisher.location | 네델란드 | - |
| dc.identifier.doi | 10.1016/j.jpha.2024.100996 | - |
| dc.identifier.scopusid | 2-s2.0-85207098027 | - |
| dc.identifier.wosid | 001381742900001 | - |
| dc.identifier.bibliographicCitation | Journal of Pharmaceutical Analysis, v.14, no.11, pp 1 - 16 | - |
| dc.citation.title | Journal of Pharmaceutical Analysis | - |
| dc.citation.volume | 14 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 16 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | DESIGN | - |
| dc.subject.keywordPlus | PREDICTIONS | - |
| dc.subject.keywordPlus | EXPRESSION | - |
| dc.subject.keywordAuthor | Vaccine manufacturing | - |
| dc.subject.keywordAuthor | Microfluidic device | - |
| dc.subject.keywordAuthor | XGBoost | - |
| dc.subject.keywordAuthor | Bayesian optimization | - |
| dc.subject.keywordAuthor | Self-validated ensemble model | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
